Breathing against resistance lowers blood pressure, and the case looks closed

High blood pressure is one of the most consequential numbers in health, and most non-drug approaches to lowering it demand substantial time and sweat. Inspiratory muscle strength training takes a different route: it loads the muscles used to breathe in against resistance, a practice earlier work hinted could nudge blood pressure downward. What has been missing is a clear answer on whether the effect is real and reliable, and which protocol, at what resistance and for how long, delivers the most. This review set out to settle both questions at once.

The authors searched 12 databases up to July 2022 for randomised controlled trials that used inspiratory muscle strength training to lower blood pressure. Twelve articles from five countries qualified, covering 386 participants, with a mean study quality score of 5.83. They pooled changes in systolic, diastolic and mean arterial pressure alongside heart rate variability. They then ran a trial sequence check, a technique that asks whether the accumulated evidence is already sufficient to call a result conclusive or whether more trials could still overturn it.

Pooled across trials, systolic blood pressure fell by 7.93 mmHg and diastolic by 3.80 mmHg, and the sequential check judged both findings conclusive. Mean arterial pressure moved by 4.90 mmHg, but with too much uncertainty to count as a clear effect. Heart rate variability results varied considerably between studies, so no firm conclusion emerged there. The training was well tolerated across different populations, and the strongest protocols were 8-week programmes using either high resistance, or low resistance combined with slow breathing.

Trials of breathing-based training have tended to be small and scattered, and this pooling suggests the systolic and diastolic effects are unlikely to be overturned by more trials of the same kind. What remains unproven is the proposed mechanism: the idea that the training lowers pressure by rebalancing sympathetic and vagal nervous activity was not confirmed here, since heart rate variability findings stayed inconsistent. The authors also note that nothing much beyond 3 months has been tested, so durability is an open question, as is the influence of breathing rate itself.

This is a reason to take resisted breathing training seriously as a blood pressure tool rather than a curiosity: the pooled drop in systolic pressure was substantial, the approach was well tolerated, and the analysis suggests the core finding is stable. It is equally a reason for measured expectations, since long-term effects are untested and the finer protocol details are still being worked out. Anyone managing blood pressure medically can reasonably treat this as background knowledge rather than a replacement for their existing plan.